This content is machine translated ASH in Atlanta The throne wavers ECHELON-1 is the first positive data available on brentuximab vedotin in first-line Hodgkin lymphoma. And things are also progressing in CLL. Chemotherapy-free variants hold their own in recurrences.
View Post 5 min This content is machine translated ICML 2017 in Lugano Long-term data are positive At the ICML Congress, the audience gained insight into long-term data from two phase III trials in mantle cell lymphoma and chronic lymphocytic leukemia. The new results confirm the statements…
View Post 6 min This content is machine translated Medidays: Update Hematology Anemia, new anticoagulants, and CLL. At Medidays, the internal medicine training program of the University Hospital Zurich (USZ), presentations were also given on various hematology topics. How is anemia meaningfully clarified? Which patients should be…
View Post 4 min This content is machine translated Chronic lymphocytic leukemia Not only ibrutinib attracts attention For patients with refractory or relapsed chronic lymphocytic leukemia, several agents are currently under investigation that show promising results. At the EHA Congress in Milan, the main focus was on…
View Post 6 min This content is machine translated Nodal lymphoma from the pathology point of view Update for daily practice A persistent lymphadenopathy is a clear indication for further histopathological diagnosis. A detailed medical history as well as knowledge of previous diseases, manipulations and drug therapies are essential for a…
